Intra-Arterial Tirofiban After Complete Recanalization for Acute Intracranial Large-Vessel Occlusion

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 344 participants.

Also called NCT07537933

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 344 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07537933
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07537933. Randomized; single masking; primary purpose treatment. Start 2026-04 (anticipated); primary completion 2028-04 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intra-Arterial Tirofiban After Complete Recanalization for Acute Intracranial Large-Vessel Occlusion
Acronym
IA-Tirofiban
Condition
Acute Ischemic Stroke
Condition
Large-vessel Occlusion
Condition
Endovascular Treatment
Intervention (Drug)
Tirofiban
Lead sponsor
Shandong Provincial Hospital (class: other government)

Record details

Record id
cardio:ct-nct07537933
Content hash
0a41eef4005e902ee32b9a36e60c51ffb5d637e8616b394391ba920308aa7e87